Regulation of endothelial cell chromatin availability and transcription factor activity during arterial-venous specification
Development · 2026-06-01 · 153 (11)
DOI: 10.1242/dev.205530 ↗At a glance
Journal article in Development, published online on 2026-06-02. Written by Nicholas W Chavkin and 6 co-authors. Institution: Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA 98101, USA. Major MEDLINE topics: Chromatin, Endothelial Cells, Arteries, Veins. 51 references. The full text is freely available in PubMed Central. Funded by: NIH HHS, NIA NIH HHS, NHLBI NIH HHS.
Abstract (original language)
Arterial-venous specification of endothelial cells during vascular development requires coordination between intracellular signaling, cell cycle state and transcription factor activity. However, the intrinsic regulatory mechanisms that govern these processes are poorly understood. To investigate this, we assessed endothelial chromatin accessibility during vascular development. Murine postnatal day (P) 6 and P15 retinal endothelial cells were analyzed by single cell assay for transposase accessible chromatin sequencing, revealing heterogeneous chromatin accessibility across an arterial-venous continuum and in distinct cell cycle states. Enhancer regulatory network analysis predicted transcription factors with differential cell cycle and arterial-venous activity, and many with dual activator and repressor functions, including SOX17. We then validated SOX17 function in human endothelial cells, identifying that it inhibits proliferation and promotes arterial gene expression. Our findings suggest that dual roles of key endothelial transcription factors are regulated by chromatin accessibility in a cell cycle- and subtype-specific manner to control arterial-venous specification.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA 98101, USA.
- Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195, USA.
- Department of Cell Biology and Developmental Genomics Center, University of Virginia School of Medicine, Charlottesville, VA 22903, USA.
- Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, CA 94305, USA.
- Department of Urology, Stanford University, Stanford, CA 94305, USA.
- Department of Developmental Biology, Stanford Cardiovascular Institute, Stanford University, Stanford, CA 94305, USA.
ORCID profiles: Karen K Hirschi
Funding
- NIH HHS
- NIA NIH HHS
- NHLBI NIH HHS
- NIDDK NIH HHS
- American Heart Association-American Stroke Association
- American Heart Association
- National Institutes of Health
Cite
APA
Chavkin, N. W., Nelson, E. A., Bradecamp, G., Aragon, J. W., Ang, L. T., Loh, K. M., & Hirschi, K. K. (2026). Regulation of endothelial cell chromatin availability and transcription factor activity during arterial-venous specification. Development, 153(11). https://doi.org/10.1242/dev.205530
Vancouver
Chavkin NW, Nelson EA, Bradecamp G, Aragon JW, Ang LT, Loh KM, et al. Regulation of endothelial cell chromatin availability and transcription factor activity during arterial-venous specification. Development. 2026;153(11). doi:10.1242/dev.205530
BibTeX
@article{Chavkin2026,
author = {Chavkin, Nicholas W and Nelson, Elizabeth A and Bradecamp, Grace and Aragon, Jordon W and Ang, Lay Teng and Loh, Kyle M and Hirschi, Karen K},
title = {Regulation of endothelial cell chromatin availability and transcription factor activity during arterial-venous specification},
journal = {Development},
year = {2026},
volume = {153},
number = {11},
doi = {10.1242/dev.205530}
}
EUVIMED